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Peritoneal dialysis (PD) has attained increased relevance as continuous renal replacement
therapy over the past years. During this treatment, the peritoneum functions as dialysis
membrane to eliminate diffusible waste products from the blood-stream. Success and
efficacy of this treatment is dependent on the integrity of the peritoneal membrane.
Chronic inflammatory conditions within the peritoneal cavity coincide with elevated levels
of proinflammatory cytokines leading to the impairment of tissue integrity. High glucose
concentrations and glucose metabolites in PD solutions contribute to structural and
functional reorganization processes of the peritoneal membrane during long-term PD. The
subsequent loss of ultrafiltration is causal for the treatment failure over time. It was shown
that peritoneal mesothelial cells are functionally connected via Nanotubes (NTs) and that a
correlation of NT-occurrence and defined pathophysiological conditions exists. Additionally,
an important participation of NTs during inflammatory reactions was shown. Here, we
will summarize recent developments of NT-related research and provide new insights
into NT-mediated cellular interactions under physiological as well as pathophysiological
conditions.
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SECTION
Peritoneal dialysis (PD) is an accepted alternative to hemodial-
ysis in the treatment of end-stage renal disease. However, when
compared internationally, PD-treatment is still underrepresented
in Germany (Lameire and Van Biesen, 2010). In this treatment,
the peritoneal membrane functions as semipermeable membrane
allowing for ultrafiltration and diffusion (Krediet, 1999). In order
to produce osmotically induced ultrafiltration, heat sterilized
glucose containing dialysis solutions are used to ensure hyperos-
molarity. The heat sterilization leads to the formation of glucose
degradation products (GDPs) (Wieslander et al., 1995) which
mainly contribute to the formation of advanced glycation end-
products (AGEs) includingmethylglyoxal (MG) (Nakayama et al.,
1997; Muller-Krebs et al., 2008). The implantation and presence
of an indwelling catheter, high glucose concentrations, and GDPs
in the dialysis solutions as well as peritonitis - a known com-
plication of PD - coincide with high levels of proinflammatory
cytokines within the peritoneal cavity and subsequent induce
chronic inflammatory conditions leading to structural and func-
tional changes of the peritoneal membrane (Witowski et al., 2000;
Flessner et al., 2007, 2010).
Moreover, a strong induction of the expression of the receptor
for advanced glycation end-products (RAGE) in the peritoneal
membrane of uremic patients was demonstrated which further
increased after PD treatment (Kihm et al., 2008), showing AGE-
RAGE interactions being crucial in peritoneal damage due to
inflammatory conditions, uremia, and PD. The resulting loss of
ultrafiltration, as well as progressive fibrosis, angiogenesis, and
vascular degeneration limit long-term PD-treatment (Margetts
and Churchill, 2002; Devuyst et al., 2010).
It is now clear that peritoneal mesothelial cells, specialized
epithelial cells that line the peritoneal cavity, not only function as
non-adhesive surface to facilitate intracoelomic movement. These
cells are crucial for the maintenance of peritoneal homeostasis,
transport processes across the peritoneal membrane and tissue
repair (Mutsaers, 2004; Yung and Chan, 2007). Furthermore, they
provide defense against bacterial insult and are essentially exposed
to the bioincompatible dialysis solutions during PD-treatment.
In response to Tumor-Necrosis-Factor (TNF) and Interleukin-1
(IL-1) secreted by peritoneal macrophages, peritoneal mesothe-
lial cells synthesize various cytokines, including IL-1, IL-6, and
IL-8, thus enhance the inflammatory signal and recruit leuko-
cytes in the peritoneal cavity (Douvdevani et al., 1994; Topley,
1995; Li et al., 1998). In the immune system, peritoneal mesothe-
lial cells bear an effective antigen-presenting function for T cells
and thereby play a relevant role during the immune response
in the peritoneal cavity e.g., during peritonitis (Valle et al.,
1995; Hausmann et al., 2000). However, with increasing PD-
treatment, peritoneal mesothelial cells undergo a progressive loss
of their epithelial phenotype toward a myofibroblast-like phe-
notype (Yanez-Mo et al., 2003). Thereby, a loss of characteristic
cell-cell junctions, apical-basal polarity as well as reorganization
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of the cytoskeleton and reprogramming of the gene expression
take place (Lamouille et al., 2014). This differentiation process,
known as epithelial-mesenchymal transition (EMT), reflects the
enormous plasticity of mesothelial cells (Yung and Chan, 2012).
In the context of inflammatory immune reactions, intercellu-
lar communication plays a crucial role. In 2004, the discovery of
Nanotubes (NTs) mediating membrane continuity has extended
the understanding of cell-to-cell communication (Rustom et al.,
2004). These NTs were initially characterized as thin intercellular
membrane channels, formed between cultivated pheochromocy-
toma (PC12) cells at their nearest distance and without contact
to the substratum (Figure 1A), displaying diameters from 50
to 200 nm and lengths of up to several cell diameters (Rustom
et al., 2004). NTs contain F-actin and/or microtubule backbones
and facilitate the intercellular transmission of various cellular
components, including organelles as well as plasma membrane
constituents or the transfer of electric signals (Hurtig et al.,
2010; Wang et al., 2010; Wang and Gerdes, 2012). Meanwhile,
NTs have been found to be present in cultures of different cell
types including for example mesothelial (Figure 1B) and epithe-
lial cells, fibroblasts, immune cells, and neurons (Vidulescu et al.,
2004; Castro et al., 2005; Watkins and Salter, 2005; Davis and
Sowinski, 2008; Gerdes and Carvalho, 2008; Pontes et al., 2008;
Ranzinger et al., 2011). Moreover, recent research demonstrates
the existence of NTs in human primary tumors (Lou et al., 2012).
During the last 10 years, a lot of knowledge concerning for-
mation, function, and biological implications of NTs in health
and disease has been gained. Aside from mediating functional
connectivity between various cell types, it is now clear that
NTs participate in several pathological processes of substantial
medical interest. NTs were proposed to be involved in the inter-
cellular spread of prion proteins (Gousset and Zurzolo, 2009;
Dunning et al., 2012) and viral proteins, e.g., during HIV infec-
tions (Eugenin et al., 2009; Kadiu and Gendelman, 2011; Sowinski
et al., 2011), the transfer of drug resistance between cancer cells
(Pasquier et al., 2012) or the transfer of Aβ peptides in the con-
text of Alzheimer’s disease (Wang et al., 2011). Moreover, it could
be demonstrated that the number of NTs in humans is depen-
dent on the individual donor background (Ranzinger et al., 2011)
and correlates with defined pathophysiological conditions. In
in vitro experiments, in which cells were stimulated with TNF,
the number of NTs is significantly increased and associated with a
remodeling of the actin cytoskeleton. This finding could be con-
firmed when NT-numbers were investigated between cells from
PD-patients (Ranzinger et al., 2011) pointing to an important
participation of NTs during inflammatory reactions.
Additionally, a strong correlation of NT occurrence with cellu-
lar cholesterol contents and its distribution throughout the cell
could be demonstrated. Experiments, in which cellular choles-
terol homeostasis in HPMCs was affected by cholesterol deple-
tion via methyl-β-cyclodextrin (MβCyc), revealed that gradual
cholesterol depletion results in a strong, non-linear modula-
tion of NT-numbers and lengths with significant peaks at given
MβCyc concentrations, pointing to narrow windows of defined
FIGURE 1 | Schematic model of molecular mechanisms with
implications for NT-mediated cellular interactions during PD. (A) The
cartoon depicts the principle of NT-formation and NT-mediated transfer of
organelles between cells. (B) The fluorescence microscopy picture shows
NTs (arrows) spanned between primary human peritoneal mesothelial
cells. (C) Illustration of the interdependence of NT-formation and
communication in the context of PD-treatment including
stimulating/inhibiting factors.
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cholesterol contents being beneficial or detrimental, e.g., by
affecting NT tensile strength or by influencing the formation pro-
cess (Ranzinger et al., 2011). The finding that statin-treatment of
HPMCs resulted in significantly increased NT-numbers coincides
with comparably high numbers of NTs found between cells from a
patient undergoing statin treatment (Ranzinger et al., 2013). In a
recent study, Thayanithy et al. (2014) explored exosomes and lipid
rafts as mediators of NT-formation in mesothelioma cells. Their
results provide evidence for exosomes as chemotactic stimuli for
NT-formation and lipid raft formation as potential biomarker for
NT-forming cells.
To date, aside from inflammatory conditions, several factors
are known that lead to the induction of NT-formation, among
these oxidative stress as well as several receptor-ligand interac-
tions (Martinez et al., 2002; Zhu et al., 2005; Chinnery et al.,
2008; Ranzinger et al., 2011; Wang et al., 2011; Sun et al., 2012).
In the context of PD-treatment, the use of dialysis solutions lead
to a significant reduction in NT-numbers between peritoneal
mesothelial cells (Ranzinger et al., 2011). Observed more closely,
oxidative stress caused by both methyglyoxal (MG) and acidified
pH-value results in higher NT-numbers whereas alterations in
cellular osmolarity due to enhanced glucose concentrations lead
to a strong decrease in NT-numbers between the cells (Ranzinger
et al., 2014). In this context, by blocking of RAGE, whose expres-
sion is upregulated during PD-treatment, it could be shown that
this receptor is a strong regulator in NT-formation processes
between murine and human peritoneal mesothelial cells in vitro
and in vivo (Ranzinger et al., 2014).
Respective underlying molecular mechanisms involved in the
formation of NTs are controversially discussed. Studies from
Wang et al. (2011) showed that NT-formation in primary rat
hippocampal astrocytes and neurons is dependent on the acti-
vation of the tumor suppressor protein p53 through hydrogen
peroxide induced cellular stress. Andresen et al. (2013) however
showed that p53 is dispensable for NT-formation in SAOS-2 cells
and dKO-MSCs. The results of these studies demonstrate that
signaling pathways and involved proteins having an impact on
the formation of NTs act strongly cell-type dependent. A pre-
vious study from Zhu et al. (2005) showed that oxidative stress
induced by H2O2 increases the formation of NTs in astrocytes
through activation of the p38 mitogen-activated protein kinase
(MAPK) pathway. In the context of RAGE being involved in
the formation of NTs between peritoneal mesothelial cells, the
MAPK signaling cascade, which is addressed upon RAGE acti-
vation, was investigated in a recent study from Ranzinger et al.
(2014). It could be demonstrated that oxidative stress induced by
MG not only induces NT-formation but also increases phospho-
rylated p38 protein levels. Subsequently, blocking of p38 resulted
in reduced NT-numbers between the cells arguing that the
action of p38 regulates NT-formation in peritoneal mesothelial
cells.
The existence of NTs in vivo has been supported by an
increasing number of publications (Eugenin et al., 2009; Pyrgaki
et al., 2010; Caneparo et al., 2011; Ranzinger et al., 2014).
However, their occurrence, architecture, and function in the body
is still a matter of considerable debate and may vary in accor-
dance to the respective species, tissue, developmental stage, age,
genetic background, and pathophysiological variations. One pos-
sible function could be a NT-mediated rescue for cells and/or
organs under pathophysiological conditions like oxidative stress
(Figure 1C).
In this view, several studies showed e.g., the transfer of mito-
chondria via NTs (Koyanagi et al., 2005; Domhan et al., 2011;
Wang et al., 2011). A study from Vallabhaneni et al. (2012)
showed that vascular smooth muscle cells initiate proliferation
of mesenchymal stem cells through the exchange of mitochon-
dria in co-cultures. Pasquier et al. (2013) demonstrated that
cancer cells acquiring mitochondria from endothelial cells dis-
play significant chemoresistance. Furthermore, work from Spees
et al. (2006) could demonstrate that aerobic respiration in cells
with dysfunctional mitochondria could be rescued by mitochon-
drial transfer. More recently, concerning ischemia/reperfusion
(I/R)-induced injury of the kidney, in a RAGE knockout mouse
model, it could be shown that under conditions where RAGE is
absent, NT-numbers are increased and kidney tissue morphology
is improved compared to kidneys fromwild-typemice (Ranzinger
et al., 2014). Interestingly, when RAGE is blocked and dialysis
solution as secondary stimulus has been applied, increased NT-
numbers could also be demonstrated in peritoneal mesothelial
cells (Ranzinger et al., 2014). In these cases, one could specu-
late that a protective effect for the respective organ/tissue might
be attributed to an increased NT-formation accompanied by
frequent exchanges of for example mitochondria.
In the future, further investigations are needed to investigate
NT-mediated transport mechanisms within the peritoneal cav-
ity in greater detail. This will have significant impact on the
understanding of a variety of processes, such as inflammatory
immune reactions. Potentially, this knowledge will allow for the
development of improved treatment options during peritoneal
infection.
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